Concert Pharmaceuticals' GAAP loss for 9M 2021 was $43.922 million, down 16.1% from $52.376 million in the previous year. Revenue increased 4.1 times to $32.565 million from $7.895 million a year earlier.
Concert Pharmaceuticals' GAAP loss for 9M 2021 was $43.922 million, down 16.1% from $52.376 million in the previous year. Revenue increased 4.1 times to $32.565 million from $7.895 million a year earlier. 
ir.concertpharma.com
English (US) 